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M. MeyyappanAbstract
Neurochemicals such as dopamine (DA) and serotonin (S-HT) are linked to disorders such as Parkinson’s disease,
epilepsy, addiction and many others. Detection of and monitoring these neurochemicals in vivo and in vitro has
become important in treating various disorders. The electroactive nature of DA and S-HT has enabled employing
electrochemical techniques to detect them at low concentrations, and a variety of electrodes and approaches have
been reported. The use of nanomaterials such as carbon nanotubes, graphene and nanowires has been advocated
in recent years for the sensitive detection of neurochemicals. This article reviews the advances in nano biosensors
for this application and discusses the future outlook and challenges.
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Research activities on nanomaterials such as carbon nano-
tubes (CNTs), graphene, various inorganic nanowires and
nanoparticles have grown exponentially over the last two de-
cades. The nanomaterials offer interesting and unique elec-
trical, mechanical, optical and other properties compared to
their bulk counterparts. Exploiting these differences to con-
struct useful devices, systems and architecture is expected to
benefit all economic sectors, and the research activities span
all areas of science and engineering [1–4]. Sensor technology
is one of the areas to reap the benefits of nanoscience and
technology, offering tremendous potential to develop sen-
sors for early warning of infectious diseases, cancer diagnos-
tics, and lab-on-a-chip for rapid and inexpensive routine
health monitoring involving blood and urine analysis [5]. A
subset of medical diagnostics to benefit from nanosensors
includes sensitive detection of neurochemicals for the treat-
ment of various neural disorders such as Parkinson’s disease,
epilepsy, etc. [6–8]. This article first provides a brief back-
ground on neurochemicals, biosensors and nanomaterials
and then reviews the sensor development efforts to date.
This is followed by a detailed discussion of carbon nanofiber
electrodes developed in our laboratory for this purpose and
finally, future outlook and challenges are summarized.1.1 Neurochemicals and the need for monitoring
Neurotransmitters are chemicals in the brain that transmit
signals from the neurons to the target cells. DopamineCorrespondence: m.meyyappan@nasa.gov
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in any medium, provided the original work is p(DA) and Serotonin (5-HT) are two of these chemicals,
which have been associated with a number of neural
disorders [9–15]. Dopamine concentration is associated
with Parkinson’s disease, epilepsy and addiction. Insuffi-
ciency of dopamine is thought to cause Parkinson’s disease
whereas excess release of DA leads to schizophrenia. Simi-
larly, serotonin levels are linked to disorders such as ad-
diction and depression. Both DA and HT-5 are present in
very small quantities in a sea of ascorbic acid (AA) with
100 – 1000 times higher concentration. Most of the detec-
tion techniques used in the literature and reviewed here,
especially the electrochemical techniques, have the advan-
tage of fast response time, but the real challenge is the
selectivity between DA and HT-5 in AA. The two neuro-
chemicals have oxidation potentials close to each other,
separated only by 150 mV. Therefore, many conventional
electrodes have difficulty yielding very distinct peaks for
the two targets especially when both are present together
in AA at realistic concentration levels. This has prompted
the investigation of nanomaterial based electrodes or
modification of conventional electrodes with coatings of
nanomaterials.
In addition to recording the concentrations of neuro-
chemicals, electrodes are desired for stimulation as well
[9, 10] since some of the neural disorders are treated by
deep brain stimulation (DBS). The stimulation is be-
lieved to produce evoked release of the neurochemicals.
Therefore, monitoring the released chemicals adds to
the importance of developing sensitive techniques to
provide feedback for the DBS procedure and improven Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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trode inserted in the brain for DBS, which is typically
1.3 mm in diameter with four 1.5 mm contacts. This elec-
trode is used for stimulation only at present without any
feedback from monitoring the concentrations of neuro-
chemicals. Targeted activation of specific and precise loca-
tion with a much smaller electrode along with guidance/
feedback from measured neurotransmitter levels is highly
desirable. Nanoelectrodes have the potential to meet this
challenge, and the requirements would include ultrahigh
sensitivity ~1 nM, fast speed of 10 ms resolution and reli-
ability and stability for long term implantation.
1.2 Biosensors
Biosensors are devices that provide the surface to host
the probe-target interaction and translate this inter-
action into some form of a measurable signal. The signal
output can be in many forms: optical, deflection of a
cantilever, electrical or electrochemical signals [5, 16–
19]. The International Union of Pure and Applied
Chemistry (IUPAC) defines a biosensor as “a device that
uses specific biochemical reactions mediated by isolated
enzymes, immunosystems, tissues, organelles, or whole
cell to detect chemical compounds usually by electrical,
thermal or optical signals” [5]. Of these, optical methods
have been well developed and shown capable of detect-
ing down to a single molecule. They are commonly
fluorescence based wherein the bio-recognition mole-
cules or probes are labeled with fluorescent tags (ex-
ample: dye) and the probe-target interaction results in aFig. 1 Schematic of the electrode in deep brain stimulation. Image courtesfluorescent signal. The intensity relates to the concentra-
tion of the target molecules and capture efficiency.
Though labeling is laborious, label-free optical tech-
niques have been developed as well.
Electrical biosensors may take the form of bio field ef-
fect transistor (BioFET) wherein the conventional transis-
tor gate is replaced with a liquid gate and a reference
electrode [18, 19]. When a probe is attached to the gate,
the current–voltage (I-V) characteristics would shift from
the behavior of the unmodified gate. Further probe-target
interaction would bring about additional shift of the I-V
curve proportional to the concentration of the target mol-
ecules in the solution. BioFETs have been extensively in-
vestigated for the detection of various biomarkers related
to healthcare and environmental monitoring.
Another form of electrical transduction involves electro-
chemical techniques that use metal (Pt for example) or
carbon electrodes. The latter can be in the form of graph-
ite, glassy carbon, carbon paste or diamond, which have
long been in use; more recently, carbon nanotubes and
graphene have become popular as well [1, 3, 5]. These
electrodes are typically used in amperometric, potentio-
metric or impedimetric modes wherein the electrodes are
functionalized with probes that have selectivity or affinity
for the targets of interest [16, 17]. The probes in all cases
can be DNA, RNA, antibodies, aptamers etc.
1.3 Nanomaterials
Since their discovery in the early 1990s, carbon nano-
tubes have commanded significant attention in terms ofy of Jun Li
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and application development [1]. The CNTs are seamless
cylinders arising from the roll-up of graphene sheets. In
the case of single-walled carbon nanotubes (SWCNTs), a
chiral vector (n, m) defines their intrinsic properties.
When (n-m)/3 is an integer, the resulting structure is
metallic; otherwise, it is semiconducting. Multiwalled
carbon nanotubes (MWCNTs) are concentric cylinders
with a hollow core, resembling rolled-up graphite sheets.
Both SWCNTs and MWCNTs are grown by techniques
such as arc synthesis, laser ablation, chemical vapor de-
position (CVD) and plasma enhanced chemical vapor
deposition (PECVD). While all of these approaches can
produce CNTs in bulk quantities, CVD and PECVD
are suited to grow CNTs on substrates with controlled
thickness and even vertical orientation, suitable for device
fabrication. The properties of CNTs can be modified by
functionalizing them with other atomic or molecular
groups. For example, fluorination makes SWCNTs insulat-
ing [20]. Attaching bio probes of DNA, RNA, aptamers,
antibodies etc. enables development of biosensors for se-
lective capturing of biotargets of interest [1, 5]. CNTs have
been investigated for a wide variety of applications includ-
ing transistors, memory devices, chem, bio and radiation
sensors, nanoelectromechanical devices, high strength light
weight composites, batteries, supercapacitors, filters and
membranes, thermal interface materials, electrical intercon-
nects in integrated circuits, electrical cables, transparent
electrodes, shielding of electromagnetic interference, field
emission devices, catalyst support and many others [1].
Graphene is a one atom thick quasi two-dimensional
material made up of sp2-bonded carbon atoms, which
are packed in a honeycomb-like lattice. It is a semi-
metal, that is, a zero-gap semiconductor. Graphene ex-
hibits a very low resistivity of ~ 10−6 ohm-cm and a high
mobility of ~15000 cm2/v.s [3]. The Young’s modulus of
graphene is estimated to be ~1 TPa. Graphene is synthe-
sized by exfoliation of graphite or reduced graphite
oxide. CVD also is a popular method to produce gra-
phene films on nickel and copper substrates. PECVD
can provide multilayer graphene vertically oriented to
the substrate surface. Graphene has been investigated
for almost every application listed above for CNTs.
Thin films of various inorganic materials such as Si,
Ge, GaAs, InP, oxides, nitrides etc. have helped with ad-
vances in microelectronics, optoelectronics, microelec-
tromechanical systems and others. In recent years, most
of these materials have been grown in the form of one-
dimensional (1D) nanowires. When the radius of a semi-
conducting nanowire is smaller than its Bohr radius, the
bandgap increases from the corresponding value for the
thin film. Nanowires offer interesting electrical, optical,
thermal and other properties relative to their bulk coun-
terparts and therefore, have received much attention inthe development of electronic, photonic, sensor and other
devices [2].
2 Review
2.1 Sensors for neurochemical monitoring
All of the nanomaterials mentioned above have been used
for the detection of neurochemicals [21–59]. A review of
selected works is presented here. Baldrich et al. [21] pre-
pared SWCNT electrodes through entrapment of nanotubes
on the surface of protein-coated magnetic particles. This
electrode was able to distinguish the peaks of DA and uric
acid (UA) at 200 μM concentrations. Li et al. [22] modified
glassy carbon electrodes (GCEs) with SWCNTs to obtain a
DA detection limit of 50 nM with peak current linearly vary-
ing between 5 and 100 μM. A graphite electrode modified
with MWCNTs and pretreated for DA detection enabled
Moreno et al. [23] to obtain a linear response in the range of
50 nm – 1 μM in the presence of AA. Electrodes using a
nanocomposite of MWCNTs, sol gel silica and gold nano-
particles were tried by Komathi et al. [24] for the sensitive
detection of DA. The sensitivity was found to be nearly four
times smaller without the gold nanoparticles. The pores in
the silica network host MWCNTs which are hydrophobic
and silica with –NH2 group which are hydrophilic. The lat-
ter attract the ascorbate ions and reject the DA molecules,
which reside on the surface of MWCNTs and exhibit strong
electron transfer reactions. In addition, the presence of gold
nanoparticles enhances the electrocatalytic oxidation of DA.
The linear range for DA detection reported in this work is
0.1 to 30 nM. Yang et al. [25] prepared a composite of
nano-sized copper oxide / MWCNTs / nafion and used it
to modify a GCE which showed a detection limit of
0.4 μM. Aravind and Ramaprabhu [26] created a nano-
composite of Pt nanoparticles and MWCNTs and immo-
bilized it with SS-DNA to prevent nanotube agglomeration.
The SS-DNA also facilitated electron transfer reaction with
dopamine. This hybrid electrode was shown to have a DA
detection limit of 0.8 μM. Kumaraswamy and Venton [27]
modified a carbon fiber microelectrode with SWCNTs
and used it for the co-detection of DA and ST in vivo in
the striatum of anesthetized rat after administration of a
serotonin synthetic precursor. The measured concentra-
tions 24 min. after the administration were 250 nM for
DA and 130 nM for seratonin.
Kim et al. [28] modified a glassy carbon electrode (GCE)
with graphene to reduce the capacitive background
current and increase the current intensity of DA. This
allowed them to obtain a complete peak separation be-
tween DA and AA with a linear range for DA detection
between 4 and 100 μM. Alwarappan et al. [29] also used a
graphene-modified GCE but reported selective detection
results only for 1 mM each of DA, AA and serotonin.
Sun et al. [30] modified a glassy carbon electrode with gra-
phene/Pt to obtain distinct peaks in DPV curves for AA,
Fig. 2 Vertical carbon nanofibers grown by plasma enhanced chemical
vapor deposition. The nanofibers have a diameter of ~ 50 nm and
height of 3–4 μm. Image courtesy of Prabhu Arumugam
Fig. 3 (a) A 3 × 3 electrode array, (b) stimulating electrode consisting of CN
embedded in SiO2 with high sensitivity (scale bar: 1 μm). Image courtesy o
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graphene showed better performance than GC and GC/
graphene electrodes. Modification of GCE with a nano-
composite of β-cyclodextrin and graphene sheet enabled
Tan et al. [31] to obtain a linear current response in the
range of 9 nM to 12.7 μM DA in PBS. The linear range
obtained in the amperometric mode was from 0.9 to
200 μM. In both cases, the nanocomposite-modified GCE
did better than both GC and GC/graphene electrodes; this
was attributed to the mass transfer control of the electro-
chemical reaction of dopamine on the nanocomposite in
contrast to the usual adsorption-limited process. Han
et al. [32] modified a GCE with a graphene-chitosan com-
posite and compared it against a GC-chitosan electrode
for the detection of DA, AA and UA. The addition of gra-
phene was shown to increase the electrocatalytic activity
towards the oxidation of all three chemicals. Gao et al.
[33] modified a GCE with graphene oxide and showed a
detection limit of 0.27 μM DA in the presence of AA and
the oxidation peak current showed a linear relation withFs with large area (scale bar: 1 μm) and (c) recording electrode
f Jun Li
Fig. 4 Electrode response to injected dopamine (2.5 μM) in real
time [56]. Image courtesy of Jessica Koehne
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[34] modified a carbon paste electrode with graphene
oxide to obtain a DA detection limit of 15 nM in the pres-
ence of 1000-fold concentration of AA and UA. Sun et al.
[35] prepared a nanocomposite of graphene and tin oxide
nanosheets and used it to modify a carbon ionic liquid
electrode. This modified electrode provided peak currents
proportional to DA concentration in the range of 0.5 to
500 μM with a detection limit of 0.13 μM. Tsai et al. [36]
coated GCEs with Te nanowires and the modified elec-
trode was further coated with nafion to improve the sta-
bility and selectivity.
Chandrashekar et al. [38] electropolymerized L-arginine
on a carbon paste electrode to form a biopolymer and uti-
lized it for the detection of DA, AA and UA. The peak
current in the CV measurement showed a linear range for
dopamine concentration between 50 μM and 0.1 mM with
a detection limit of 0.5 μM. In addition to CNTs and
graphene, diamond based electrodes have also been ex-
plored. For example, Raina et al. [39] used a nitrogen-
incorporated nano-diamond based ultramicroelectrode
array and produced steady state CV curves for DA con-
centrations in the range of 100–800 μM in 0.1 M PBS.
Besides electrochemical approaches such as the ones dis-
cussed above, BioFETs have been used as well for detecting
dopamine. For example, Li et al. [40] fabricated an open gateFig. 5 Differential pulse voltammetry results for 1 mM AA, 10 μM DA and 1
electrode. Image courtesy of Jessica Koehneion sensitive field effect transistor and measured the I-V char-
acteristics for increasing DA concentrations from 1 fM to 1
nM. However, no data was given on how the device would
perform when DA is present in mixtures of AA and/or UA.
2.2 Carbon nanofiber electrodes for neurochemical
monitoring
Our group has been developing carbon nanofiber based
nanoelectrodes for the detection of neurochemicals and
also for stimulation in collaboration with Mayo Clinic
[56–59]. The CNFs are ~50 nm in diameter, grown by
plasma enhanced chemical vapor deposition (PECVD).
The as-grown structures are vertical and free-standing,
as shown in Fig. 2, due to the electric field perpendicular
to the wafer. The broken walls of CNFs along the outside
of the structure as evidenced by TEM analysis (data not
shown here) and the resulting defects are ideal for good
electron transfer. The fabrication of the electrodes has
been described previously [60–64] and a brief description
is provided below with the fabricated electrodes in Fig. 3.
A silicon wafer with a 500 nm thick thermal oxide is used
as substrate and a thin layer of Pt or Cr is deposited on the
substrate to provide electrical contact between the CNFs and
the measurement circuit. This is followed by sputtering of
10–30 nm nickel as catalyst layer. Acetylene is used to grow
CNFs at a pressure of 1–3 Torr and temperature of 600-
700 °C. The catalyst film breaks up into tiny droplets of
random sizes on the wafer and growth on these catalysts par-
ticles yields nanofibers shown in Fig. 3 (b). These uncoated
CNFs can be used as stimulating electrode of desirable size,
even down to a single CNF electrode of 50 nm. Patterning of
the catalyst instead of a blanket sputtered catalyst layer can
provide CNFs of specified diameter at desired locations. The
gap between the nanofibers is filled with SiO2 to provide
mechanical stability. Then the top surface of the wafer with
CNFs is subjected to chemical mechanical polishing which
results in a smooth oxide surface with few nm of CNFs pro-
truding out as seen in Fig. 3 (c). This embedded electrode is
suitable for recording neurochemical concentrations.
Figure 4 shows a color plot of the response of the elec-
trode shown in Fig. 3 (c) to injected dopamine (2.5 μM) in0 μM 5-HT [58]. (a) glassy carbon electrode and (b) carbon nanofiber
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around 60 s [56]. Fig. 5 compares the performance of this
electrode with that of a conventional GCE for a mixture
containing 1 mM of AA and 10 μM each of DA and
5-HT. The GCE is not able to resolve the peaks whereas
the CNF nanoelectrodes shows very distinct peaks in the
differential pulse voltammetry plots [58].
3 Conclusions
A review of the current status of sensors for the detec-
tion and monitoring of neurochemicals has been pre-
sented. Most electrodes do not have any difficulty in
detecting down to few nM concentrations of dopamine
by itself in buffer solutions. However, sensitive detection
of DA in mixtures of 5-HT, ascorbic acid and others is
challenging. Nanoelectrodes using CNTs, graphene and
CNFs have been reported to meet these challenges at
present. More studies demonstrating the utility of these
techniques in vivo are needed. Nanoelectrodes for stimu-
lation show much potential but no significant demon-
strations have appeared yet. This is an area that requires
further investigation.
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